Patents by Inventor David Robert Jones

David Robert Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9746842
    Abstract: One or more commercial appliances for handling food and/or one of more subsystems of commercial appliances for handling food are linked to a master controller for controlling the operation of the commercial appliance(s) and/or its subsystem(s) via one or more CAN modules and a CAN bus.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: August 29, 2017
    Assignee: Duke Manufacturing Co.
    Inventors: Robert J. Reese, Jeffrey A. Stafford, David Robert Jones, Philip Gregory Geerling
  • Patent number: 8946259
    Abstract: The present invention is directed to benzazole compounds that inhibit ?-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: February 3, 2015
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Adnan M. M. Mjalli, David Robert Jones, Devi Reddy Gohimukkula, Guoxiang Huang, Jeff Jiqun Zhu, Mohan Rao, Robert Carl Andrews, Tan Ren
  • Publication number: 20140066477
    Abstract: The present invention is directed to benzazole compounds that inhibit ?-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.
    Type: Application
    Filed: October 28, 2013
    Publication date: March 6, 2014
    Applicant: High Point Pharmaceuticals, LLC
    Inventors: Adnan M.M. Mjalli, David Robert Jones, Devi Reddy Gohimukkula, Guoxiang Huang, Jeff Jiqun Zhu, Mohan Rao, Robert Carl Andrews, Tan Ren
  • Publication number: 20130297042
    Abstract: One or more commercial appliances for handling food and/or one of more subsystems of commercial appliances for handling food are linked to a master controller for controlling the operation of the commercial appliance(s) and/or its subsystem(s) via one or more CAN modules and a CAN bus.
    Type: Application
    Filed: May 1, 2013
    Publication date: November 7, 2013
    Applicant: Duke Manufacturing Co.
    Inventors: Robert J. Reese, Jeffrey A. Stafford, David Robert Jones, Philip Gregory Geerling
  • Patent number: 8431575
    Abstract: The present invention provides phenyl-heteroaryl derivatives of Formula (I) and pharmaceutically acceptable salts thereof These compounds are useful in the treatment of RAGE-mediated diseases such as Alzheimer's Disease. The present invention further relates to methods for the preparation of compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds, and the use of such compounds and/or pharmaceutical compositions in treating RAGE-mediated diseases.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: April 30, 2013
    Assignee: TransTech Pharma, Inc.
    Inventors: Devi R Gohimukkula, David Robert Jones, Ghassan Qabaja, Jeff J Zhu, Jeremy T Cooper, William K Banner, Kurt Sundermann, Muralidhar Bondlela, Mohan Rao, Pingzhen Wang, Suparna Gupta, Anitha Hari, Raju B Gowda, Robert C Andrews
  • Patent number: 6878729
    Abstract: Compounds having a structure according to Formula (I): are effective in a method of increasing erythropoietin and vascularization of tissue in a subject in need thereof.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: April 12, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Ji-In Kim Almstead, Nicholas John Izzo, David Robert Jones, Richard Masaru Kawamoto
  • Publication number: 20040167183
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: August 4, 2003
    Publication date: August 26, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Sean Rees Klopfenstein, Matthew Brian Maier, David Robert Jones, Jeffrey Lyle Gray, Matthew Eugene Pokross, Kevin Gene Peters, Artem Gennady Evdokimov
  • Publication number: 20040053977
    Abstract: Compounds having a structure according to Formula (I): 1
    Type: Application
    Filed: September 12, 2003
    Publication date: March 18, 2004
    Inventors: Ji-In Kim Almstead, Nicholas John Izzo, David Robert Jones, Richard Masaru Kawamoto
  • Patent number: 6660737
    Abstract: Compounds having a structure according to Formula (I): are effective in a method of increasing erythropoietin and vascularization of tissue in a subject in need thereof.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: December 9, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Ji-In Kim Almstead, Nicholas John Izzo, David Robert Jones, Richard Masaru Kawamoto
  • Publication number: 20030092716
    Abstract: Compounds having a structure according to Formula (I): 1
    Type: Application
    Filed: April 29, 2002
    Publication date: May 15, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Ji-In Kim Almstead, Nicholas John Izzo, David Robert Jones, Richard Masaru Kawamoto
  • Publication number: 20030083351
    Abstract: Compounds having a structure according to Formula (I): 1
    Type: Application
    Filed: April 29, 2002
    Publication date: May 1, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Ji-In Kim Almstead, Nicholas John Izzo, David Robert Jones, Richard Masaru Kawamoto